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esses: chantal.raherisoSummary Background: Smoking is a preventable cause of increased morbidity and
mortality. Therefore, interventions have been used to assist smokers in overcoming
their addiction. The aim of the study was to describe factors associated with smoking
cessation, in patients applied to our smoking cessation (SC) unit in 1999, in a
prospective study.
Methods: Patients were followed-up during two years. Detailed medical history,
Fagerstro¨m test, Hospital Anxiety and Depression (HAD) scale questionnaire,
Motivation scale and replacement therapy were systematically recorded.
Results: Three hundred patients (58% men, 42% women) applied to the SC unit
from January to December 1999. The mean age was 42 yrs old. They smoked in
average 24 cig/d. Mean duration of smoking was 20 years. Fagerstro¨m score was 5.86
(min 0; max: 10). Patients seemed to be more anxious (score 9.6) than depressed
(5.09), according to the HAD score. 79% of them received both psychosocial
intervention, pharmacotherapy and nicotine replacement therapy. 66% of patients
were followed-up (n ¼ 198).
Two years later, the smoking cessation rate was 12% (n ¼ 36). Motivation,
Fagerstro¨m and HAD scores were not associated with the quitting rate. Quitting rate
was higher (25.9%) in patients who attempted to quit smoking for the first time than
in others (19%). By contrast, the quitting rate was significantly associated with age
(P ¼ 0:03).
Conclusion: Success to quit smoking was positively associated with age, and
negatively with alcohol dependence.
& 2004 Elsevier Ltd. All rights reserved.Elsevier Ltd. All rights reserved.
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Smoking is a preventable cause of mortality and
morbidity. Epidemic of smoking trends is nowadays a
public health problem, particularly for respiratory
diseases, COPD,1 asthma2 and lung cancer.3 Lung
cancer patients who smoke should be strongly encour-
aged to stop smoking (Recommendations grade B).4
Eagan et al. suggested a beneficial effect of smoking
cessation on the remission of respiratory symptoms.5
It has been shown that various methods of
assistance for smoking cessation such as behavioral
counseling,6 self-help, telephone,7 computer-based
interactive interventions or nicotine replacement
therapy8 could significantly increase success rates in
quitting, even in hospitalized patients.9 Previously,
minimal counseling by general practitioners has been
demonstrated to decrease smoking.10 It has been
shown that the success rate for those who sought
assistance was half the rate of those who did not seek
assistance. In addition, those who sought assistance
seemed to be heavier smokers than the others.11
Other significant factors of smoking cessation
included a low Fagerstro¨m Tolerance Questionnaire
score (p6) and the patient’s report of a current
disease but not with past history of disease
worsened by smoking. Poor health perception and
consumption of more than one pack per day predict
smoking cessation.12 The main problem remains the
initiation and maintenance of smoking cessation,
both in patients without symptoms, in patients with
COPD, with lung cancer or after curative surgery.
In another hand, from a psychological point of
view, stage of change is a variable which takes into
account past behavior and behavioral intention to
characterize an individual’s readiness to change.13 In
three representative samples, 40% are in precontem-
plation, 40% in contemplation and 20% in prepara-
tion.14,15 The initial motivation scale to stop smoking
could appreciate stages of change. By contrast,
Farkas et al. suggest that the level of addiction is a
more likely predictor of smoking cessation than are
stages of change.16 Recently, standardized scale and
questionnaires have been recommended for use in
smoking cessation unit (SCU).17
The aim of the study was to identify factors related
to smoking cessation in a population-based cohort of
adults, in our SCU, after two years of follow-up.Methods
Study population
In 1999, the whole sample of 300 consecutive
patients who came in our SCU for the first timewas studied. They were followed-up during
two years.
A follow-up survey was conducted in 2002, with
phone-interview. The patients give their inform
consent to answer a postal self-questionnaire.
Lost to follow-up were 91, dead were 11,
followed-up were 198 (66%). A total of 198 patients
replied to a mailed questionnaire.
The data were prospectively and systematically
recorded since the first patient’s consultation in a
data base, using a standardized questionnaire.
The inclusion criteria was Each consecutive patient male or female aged
418 years old consulting for smoking cessation
consultation. To be able to fulfill a questionnaire.
The was no exclusion criteria according to
motivation, risk of lost for follow-up, or depen-
dence status.
The questionnaires
First survey
Clinical examination was made by a chest specia-
list. Anthropometrics data were recorded (weight,
height), blood pressure, initial exhaled CO. Each
patient was seen by a doctor, specialized in
smoking cessation, by a psychologist, and by a
dietician.
The following variables were recorded: medical
history, cardiovascular diseases, alcohol consump-
tion, chronic bronchitis, asthma, treatment, psy-
chological history.
The auto-questionnaire recorded: gender, age,
social class, Fagerstro¨m score18 [0–10], Motivation
visual analogic scale [0–10], smoking habits with
Horn test,19 anxiety-depression test using an HAD
scale.20,21 The auto-questionnaire was given by a
nurse specialized in SC.
Age of onset of smoking, the number of cigar-
ettes smoked, pack-years and previous attempts to
stop smoking were recorded. The treatment pre-
scribed, the reasons for stopping smoking, the
number of visits during the follow-up were also
recorded.
Follow-up
The relapse since the first consultation, current
smoking habits, the duration of avoid smoking and
the reasons of the relapse according to the patient,
the number of cigarettes smoked per day, feeling
towards smoking (negative or positive), were
recorded. The follow-up procedure was: each
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the study and to be contacted two years after.
The second visit at 6 weeks was systematic then,
follow-up was according voluntary visits during the
study.Data analysis
The sample size calculation to achieve the statis-
tical analysis with a a-error of 5% and b-risk of 90%
was 300 subjects. The success of quitting smoking
was defined by the absence of cigarettes smoked
since the first survey. A descriptive analysis of the
first survey and the follow-up was done.
A comparison of subjects followed-up and lost to
follow-up was made.
Subjects with success were compared to those
with relapse. The analysis was performed with all
the subjects (intent to treat analysis). The ex-
planatory variables were gender, age, smoking
habits, pack-years, and the scores previously
described in the methods section. For qualitative
variables, the w2 test was used. For quantitative
variables, a regression analysis was used. For theTable 1 Demographic comparison between responders a
Total F
Subjects n 300 1
Age, m (SD) 42.5(10) 4
Gender (% male) 58 5
BMI (kg/m2) 23.7(4.1) 2
Exhaled CO, m (SD) 13.69(9.25) 1
Anger (%) 10 1
Myocardial ischemia (%) 9 8
Arrhythmias (%) 14 1
Hypertension (%) 19.3 1
Stroke (%) 2.3 2
Depression (%) 25 2
Anxiety (%) 25.7 2
Alcohol (%) 15 1
Cancer (%) 2.3 2
Allergies (%) 9 8
HIV (%) 2 1
Chronic bronchitis (%) 19 1
Asthma (%) 10 8
Dyspnoea (%) 57 5
Snoring (%) 38.7 4
Social class (%)
Employees 68.3 7
Job seeker 8.3 7
Retired 8.3 7
Unemployed 15 1score, two approaches were made: first as categor-
ial variable with different cut-off, and second
means of the score.
A significance level of 0.05 was chosen.
The analysis was made using the logiciel SPSS
11.0.Results
In 1999, the whole sample of 300 consecutive
patients who came in our SCU for the first time was
studied. A follow-up survey was conducted in 2002,
with phone-interview. Lost to follow-up were 91,
dead were 11. A total of 198 patients (66%) replied
to a mailed questionnaire. No difference was found
according to demographic characteristics between
the two groups (Table 1).
By contrast, the only significant difference in
smoking habits between the two groups was the
initial motivation, which was lower in the non-
responders (Table 2).
Among 300 patients followed-up, 36 declared
having quitted smoking (12%) after the firstnd non responders.
ollowed up Lost to follow-up P
98 102
2.8(10.9) 42.4(11.3) 0.77
7.5 58.8 0.83
3.6(4.1) 23.7(4.09) 0.47
3.7(9.4) 13.6(8.8) 0.46
0.1 9.8 0.23
.6 9.8 0.21
3.6 14.7 0.21
8.7 20.6 0.34
2.9 0.49
3.7 27.7 0.29
4.2 28.4 0.27
3.1 18.6 0.14
2.9 0.32
.1 10.8 0.18
3.9 0.1
6.2 24.5 0.21
.6 12.7 0.26
5.6 59.8 0.67
0.4 34.3 0.36
3.2 58.8 0.07
.6 9.8
.1 10.8
2.1 20.6
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older than the others (P ¼ 0:03). There was no
significant difference between the two groups
according to co-morbidity, cardiovascular or re-
spiratory disease. There was a little trend in the
success group to be more retired, and to have less
alcohol dependence (Table 3).
Surprisingly, we did not find any difference
between the two groups according to Fagerstro¨m
test, motivation scale, Horn test, HAD test, and
number of cigarettes smoked per day (Table 4).
Patients seemed to be more anxious than de-
pressed, according to the HAD score. The only
difference was the number of visits, increased
significantly in the success group. A separated
analysis was performed, comparing the groups
according the number of visits according to initial
motivation scale, Fagerstro¨m test and the other
variables for smoking habits, the results remained
unchanged.
The frequency of quit smoking success was
inversely correlated to the previous attempts to
stop smoking (Fig. 1), without difference according
to age, gender, social class.
Cost of tobacco, dependence to cigarettes, and
interdiction did not seem to be the reasons to
stop smoking for the subjects in the success group
(Table 5).
Seventy nine percent of them received both
psychosocial intervention, pharmacotherapy and
nicotine replacement therapy.Table 2 Smoking habits according to response at follow
Total
Subjects 300
Fagerstro¨m, m (SD) 5.86(2.29)
Motivation, m (SD) 7.3(3.4)
Horn test total, m (SD) 50.9(9.5)
Stimulation, m (SD) 6.3(2.5)
Pleasure, m (SD) 7.6(2.4)
Relaxation, m (SD) 10.5(2.4)
Support, m (SD) 10.6(3.1)
Dependence, m (SD) 8.8(2.5)
Habits, m (SD) 7(2)
HAD test total, m (SD) 16.1(6.9)
Anxiety test, m (SD) 10.6(4.3)
Depression test, m (SD) 5.6(3.6)
Age of onset smoking, m (SD) 17.7(4.6)
Number of cig/day, m (SD) 24(11)
Pack-years 25
Nocturnal wake-up for smoking (%) 2.4
Cost related to cig/month (euros) 101Discussion
In this prospective study, success to quit smoking
was positively associated with age, and negatively
with alcohol dependence. The frequency of success
to quit smoking was inversely correlated to the
previous attempts to stop smoking. In addition, the
number of visits was significantly associated with
quit smoking rate.
We cannot formally exclude a selection bias in
our study, because our patients were smokers
volunteers who visit to the hospital smoking
cessation unit. However, there was no difference
between responders and non-responders.
Another difficulty in our study was that the
patient, without objective measure of cotinine or
CO expired, declared quitting smoking. Our ap-
proach was a pragmatic approach, for a first
evaluation of our smoking cessation unit, usually
used in this kind of study, using self-administered
questionnaire or cross-sectional telephone survey,
even in published meta-analysis.10,22 Measures of
quitting activity are important to evaluate public
health intervention and the likelihood of future
quitting in the individual smoker. Respondents
often forgot dates of quit attempts than the most
recent attempt.23,24
In a meta-analysis published by the Cochrane
group, 34 trials were identified including over
27,000 smokers. Pooled data from 16 trials were
analyzed. The main outcome measures were-up.
Followed up Lost to follow-up P
198 102
5.7(2.2) 6.2(2.1) 0.13
7.8(2.2) 7(2.3) 0.009
50.9(9.5) 51.4(10.2) 0.68
6.3(2.4) 6.2(2.8) 0.71
7.6(2.4) 7.8(2.5) 0.53
9.5(2.4) 10.5(2.4) 0.94
10.5(3) 10.7(3.02) 0.62
8.7(2.5) 9(2.4) 0.37
6.9(1.9) 7.3(2.2) 0.15
16.1(6.8) 16.1(7) 0.94
10.5(4.2) 10.6(4.3) 0.75
5.6(3.4) 5.5(3.8) 0.27
17.6(4.6) 17.8(4.8) 0.68
23.7(11) 25.2(11) 0.28
23 25 0.3
3 1.2 0.66
100.9 112 0.08
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Table 3 Demographic data according to relapse at two years follow-up.
Relapse Success P
Subjects n 264 36
Age, m (SD) 42(11.7) 46(10.7) 0.034
Gender (% male) 58.3 55.6 0.75
BMI (kg/m2), m (SD) 23.7(4.1) 23.6(4.2) 0.90
Exhaled CO at the first visit, m (SD) 13.8(8.5) 12.9(13.1) 0.6
Angor (%) 9.8 11.1 0.71
Myocardial ischemia (%) 8.7 11.1 0.66
Arrhythmias (%) 13.9 14 0.72
Hypertension (%) 18.6 25 0.27
Stroke (%) 2.7 0 0.48
Depression (%) 25 25 0.36
Anxiety (%) 25 30.6 0.31
Alcohol (%) 16.3 5.6 0.06
Cancer (%) 2.3 2.8 0.75
Allergies (%) 9.5 5.6 0.57
HIV (%) 2.3 0 0.46
Chronic bronchitis (%) 19.7 13.9 0.28
Asthma (%) 10.6 5.6 0.27
Dyspnoea (%) 57.6 52.8 0.59
Snoring (%) 39 33.3 0.51
Social class (%)
Employees 67.4 75 0.21
Job seeker 9.1 2.8
Retired 7.6 13.9
Unemployed 15.9 8.3
Table 4 Smoking habits according to relapse at two years follow-up.
Relapse Success P
N ¼ 264 N ¼ 36
Fagerstro¨m, m (SD) 5.9(2.1) 5.9(2.6) 0.69
Motivation, m (SD) 7.47(0.18) 7.96(0.44) 0.77
Horn test total, m (SD) 51.1(9.3) 51.2(12.5) 0.92
Stimulation 6.3(2.3) 6.7(2.7) 0.36
Pleasure 7.6(2.3) 7.5(2.8) 0.35
Relaxation 10.59(2.3) 10.38(2.8) 0.22
Support 10.7(3) 10.7(3) 0.96
Dependence 8.6(2.5) 8.9(2.5) 0.54
Habits 6.9(1.9) 7(2.2) 0.88
HAD test total, m (SD) total 15.9(6.9) 17.4(6.9) 0.25
Anxiety test 10.4(4.3) 11(4.3) 0.48
Depression test 5.4(3.5) 6.4(3.6) 0.14
Age of onset smoking, m (SD) 15.8(6.9) 17.3(3.9) 0.24
Number of cig/day, m (SD) 24(10.7) 25.9(13.3) 0.35
Pack-years 31 30 0.97
Nocturnal wake-up (%) 2.2 3.2 0.88
Cost related to cig/months, (euros) 101 97.48 0.66
Number of visits 1.79 3.89 0.005
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Table 5 Reasons to stop smoking according to
relapse.
Relapse Success P
N ¼ 264 N ¼ 36
Cost of tobacco (%) 44.2 22.9 0.01
Health’s problems (%) 60.1 60 0.42
Recent surgery (%) 10.4 17.1 0.24
Anxiety (%) 91.4 88.9 0.4
To feel dirty (%) 24.2 22.9 0.52
Slavery (%) 78.7 61.1 0.02
Pleasure (%) 41.9 36.1 0.31
Interdiction (%) 10.1 0 0.04
Project in the future (%) 27.6 11.4 0.04
25.9
never 1 2 or 3
times
4 or 5
times
Number of previous attempts to stop smoking
*p=0.043
>5 times
19 13.1 7.7 11.1
100
80
60
40
20
0
%
Relapse
Success
Figure 1 Success rates according to previous attempts to
stop smoking.
C. Raherison et al.1308abstinence from smoking after at least a six months
follow-up. Validation of all self-reported cessation
by biochemical analysis of body fluids or measure-
ment of expired carbon monoxide was reported in
only 26% of the studies. Despite this, simple advice
by a doctor has been recognized to have a small
effect on cessation rates.10 In addition, some
studies analyzed the validity of self-reported of
smoking habits and showed that self-reported were
correlated with biological measures as cotinine
levels.25–27 The aim of a study reported by Patrick
et al.28 was to identify circumstances in which
biochemical assessments of smoking produce sys-
tematically higher or lower estimates of smoking
than self-reports. A secondary aim was to evaluate
different statistical approaches to analyzing varia-
tion in validity estimates. A literature searches and
personal inquiries identified 26 published reports
containing 51 comparisons between self-reported
behavior and biochemical measures. The sensitivity
and specificity of self-reports of smoking were
calculated for each study as measures of accuracy.
Sensitivity ranged from 6% to 100% (mean ¼ 87.5%),
and specificity ranged from 33% to 100%
(mean ¼ 89.2%). Interviewer-administered ques-
tionnaires, observational studies, reports by adults,
and biochemical validation with cotinine plasmawere associated with higher estimates of sensitivity
and specificity. Self-reports of smoking appeared to
be accurate in most studies.
Age seems to be a factor of success to quit
smoking, in our study. Tillgren et al. showed that in
a panel of 5104 randomized people aged 16–84
years, for both sexes, that daily consumption of
cigarettes, years spent to smoke and age were
associated with successful quitting.29 In our study,
co-morbidities were not related to quit smoking. In
the meta-analysis published by Rigotti et al.,22 the
clinical diagnosis did not affect the likelihood of
quitting, in hospitalized patients, despite the good
effectiveness of interventions for smoking cessa-
tion. Joseph et al. reported that intention to quit
was positively associated with age.30
In our study, patients with alcohol dependence
had more risk of relapse than others. Among
patients in intensive treatment for alcohol use
disorders who smoke, a history of depressive
disorder and depressive symptoms predict less
interest in quitting smoking.30 By contrast, some
authors reported that a past history of alcohol
problems per se does not predict inability to stop
smoking.31
In our study, the results showed that the subjects
had a moderate dependence to tobacco, according
to the Fagerstro¨m test. The initial motivation score
seemed to be higher in the successful group,
however the difference was not significant. Smok-
ing habits measured by the Horn test was not
different between the two groups, even for
smoking history. It has been suggested that quitters
used to smoke more cigarettes than current
smokers, and that they have a poor health percep-
tion.12 It was not the case in our study. In our
population, the subjects were more anxious than
depressed. It has been suggested that in people
who are well-acquainted with the ill-effects of
nicotine abuse, smoking habits persist and are
correlated with levels of anxiety.32
The two years quitting rate in our study at was
12%. In previous study, quitting rate in the 12
months may varied from 7% to 15%.11 There was a
little trend in the success group to be more retired.
Behavioral support and advice from a clinic run by
smoking cessation specialist is effective in aiding
smoking cessation.17 Effect of Intensive behavioral
support and NRTor bupropion,8 has been estimated
from 13% to 19%.17 In our clinic, the majority of our
patients received intensive behavioral support and
NRT. Our results are very similar to those published
in the literature.
Surprisingly, the frequency of success to quit
smoking was inversely correlated to the number of
previous attempts to stop smoking. We did not find
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between subjects according to previous attempts
to stop smoking. This result is in contradiction with
the theory proposed by Prochaska.13 In this theory,
the transtheoretical model (TTM) proposed that
success to quit smoking was positively correlated
with the higher number of previous attempts.
In the TTM, the stage effect is one of the most
important determinant of health behavior change.
Each stage is defined by intentions and behaviors.
Velicer et al. showed that each stage could be
influenced by two principal factors.33 The first one,
the positive and negative evaluation strength (four
positive and negative aspects to consider when
making a decision); the second one is the habit
strength, which refers to the psychological and
physiological aspects of smoking behavior. The
authors showed that for each stage, three sub-
stages were possible: stable, regressing, or pro-
gressing. The utility of the TTM has been discussed,
and less clear are specific strategies that the
clinician can use to move the patient along the
change continuum.34 In our study, we did not use
questions to assign stage of smoking cessation.
Because our subjects were volunteers to visit to our
SC unit, we could hypothesize that they were not at
the precomtemplation stage, but at least at the
contemplation (considering change), or prepara-
tion (making small changes), action (actively
engaging in a new behavior) stages. We can
hypothesize too that some subjects who tried to
quit smoking before, having less motivation, did
not visit our SC.
The number of visits was higher in the success
group compared to the relapse group. This could be
a marker of social support. Direct comparison
between more intensive and less intensive interven-
tions have not been adequate to enable conclusions
to be drawn, but comparisons across studies suggest
that more intensive interventions in terms of
frequency of contact and/or duration of contact
achieve higher success rates.17 However, this rela-
tion could be only due to the fact that only smokers
who succeeded giving up smoking would attend to
the follow-up visits while the others gave up.
Cost of tobacco, dependence to cigarettes, and
interdiction did not seem to be good reasons to stop
smoking for the subjects in the success group.
To conclude, our study showed in a selective
group of patients who came to a hospital cessation
unit, that age, number of visits were associated to
successful rate of quitting smoking. By contrast,
previous attempts to stop smoking were inversely
associated to successful rate. The results strongly
support the promotion of smoking cessation unit,
for smokers and general practitioners.References
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